Actin Polymerization Negatively Regulates p53 Function by Impairing Its Nuclear Import in Response to DNA Damage

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wang, Ling ^a   Wang, Min ^a   Wang, Shuyan ^a   Qi, Tianyang ^a   Guo, Lijing ^a   Li, Jinjiao ^a   Qi, Wenjing ^a   Ampah, Khamal Kwesi ^a   Ba, Xueqing ^a   Zeng, Xianlu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; AURORA A KINASE; PROTEIN P21; PROTEIN P53;

ACTIN POLYMERIZATION; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE; NUCLEAR IMPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; CYTOPLASM; DNA DAMAGE; HUMANS; ONCOGENE PROTEIN P21(RAS); PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EUKARYOTA;

EID: 84875661955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060179     Document Type: Article

References (55)

1. Meek DW, (2009) Tumor suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9: 714-723.
2. Bremner R, Balmain A, (1990) Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61: 407-417.
3. Fearon ER, Vogelstein BA, (1990) Genetic model for colorectal tumorigenesis. Cell 61: 759-767.
4. Baker SJ, Markowitz S, Fearon ER, Willson JK, (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915.
5. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, et al. (1990) p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10: 5772-5781.
6. Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, et al. (1990) Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 7: 6166-6170.
7. Martinez J, Georgoff I, Martinez J, Levine AJ, (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-159.
8. Shaulsky G, Ben-Ze'ev A, Rotter V, (1990a) Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5: 1707-1711.
9. Marine JC, (2010) p53 stabilization: the importance of nuclear import. Cell Death Differ 17: 191-192.
10. Kruse JP, Gu W, (2009) Modes of p53 regulation. Cell 137: 609-622.
11. Moll UM, Riou G, Levine AJ, (1992) Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc Natl Acad Sci USA 89: 7262-7266.
12. Moll UM, LaQuaglia M, Benard J, Riou G, (1995) Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 92: 4407-4411.
13. Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, et al. (1995) p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 147: 790-798.
14. Alarcon VD, Ronai Z, (2002) p53-Mdm2-the affair that never ends. Carcinogenesis 23: 541-547.
15. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, et al. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18: 1660-1672.
16. Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, et al. (1998) Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member. J Biol Chem 273: 29586-29591.
17. Aylon Y, Oren M, (2007) Living with p53, dying of p53. Cell 130: 597-600.
18. Staiger CJ, Blanchoin L, (2006) Actin dynamics: old friends with new stories. Curr Opin Plant Biol 9: 554-562.
19. Olson EN, Nordheim A, (2010) Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 11: 353-365.
20. Carlsson AE, (2010) Actin dynamics: from nanoscale to microscale. Annu Rev Biophys 39: 91-110.
21. Hild G, Bugyi B, Nyitrai M, (2010) Conformational dynamics of actin: Effectors and implications for biological function. Cytoskeleton (Hoboken) 67: 609-629.
22. Metcalfe S, Weeds A, Okorokov AL, Milner J, Cockman M, et al. (1999) Wild-type p53 protein shows calcium-dependent binding to F-actin. Oncogene 18, 2351-2355.
23. Jiang M, Axe T, Holgate R, Rubbi CP, Okorokov AL, et al. (2001) p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress. Oncogene 20: 5449-5458.
24. Sidani M, Wessels D, Mouneimne G, Ghosh M, Goswami S, et al. (2007) Cofilin determines the migration behavior and turning frequency of metastatic cancer cells. J Cell Biol 179: 777-791.
25. Wang XX, Liu R, Jin SQ, Fan FY, Zhan QM, (2006) Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Research 16: 356-366.
26. Li JQ, Li QX, Xie CC, Zhou HM, Wang YQ, et al. (2004) β-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death. J Cell Sci 117: 4673-4680.
27. Lambert CM Ngoka, (2008) Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers. Proteome Sci 6: 30.
28. Ivan M, Haberberger T, Gervasi DC, Michelson KS, Gunzler V, et al. (2002) Biochemical purification and pharmacological inhibition of a mammalian prolylhydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99: 13459-13464.
29. Pan X, Zhao J, Zhang WN, Li HY, Mu R, et al. (2009) Induction of SOX4 by DNA damage is critical for p53 stabilization and function. PNAS 106: 3788-3793.
30. Smart DJ, Halicka HD, Schmuck G, Traganos F, Darzynkiewicz Z, et al. (2008) Assessment of DNA double-strand breaks and γH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone. Mutat Res 641: 43-47.
31. Zuchero JB, Belin B, Mullins RD, (2012) Actin binding to WH2 domains regulates nuclear import of the multifunctional actin regulator JMY. Mol Biol Cell 23: 853-863.
32. Waldman T, Kinzler KW, Vogelstein B, (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190.
33. Asker C, Wiman KC, Selivanova G, (1999) p53-induced apoptosis as a safeguard against cancer. Biochem Biophys Res Commun 265: 1-6.
34. Bubb MR, Spector I, Beyer BB, Fosen KM, (2000) Effects of Jasplakinolide on the Kinetics of Actin Polymerization. J Biol Chem 275: 5163-5170.
35. Heptinstall JA, May H, Ratan JR, Glenn WL, (1998) GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly. Platelets 9: 227-232.
36. Maciver SK, Hussey PJ, (2002) The ADF/cofilin family: actin-remodeling proteins. Genome Biol 3: 3007-3012.
37. Ono S, (2007) The mechanism of depolymerization and severing of actin filaments and its significance in cytoskeletal dynamics. Int Rev Cytol 258: 1-82.
38. Ichetovkin I, Grant W, Condeelis J, (2002) Cofilin produces newly polymerized actin filaments that are preferred for dendritic nucleation by the Arp2/3 complex. Curr Biol 12: 79-84.
39. Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, et al. (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36: 10117-10124.
40. Engel K, Kotlyarov A, Gaestel M, (1998) Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J 17: 3363-3371.
41. Gillotin S, Yap D, Lu X, (2010) Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradation. Cell Cycle 9: 1390-1398.
42. Yap DB, Hsieh JK, Zhong S, Heath V, Gusterson B, et al. (2004) Ser392 phosphorylation regulates the oncogenic function of mutant p53. Cancer Res 64: 4749-4754.
43. Fogal V, Hsieh JK, Royer C, Zhong S, Lu X, (2005) Cell cycle-dependent nuclear E2F1 requires phosphorylation. EMBO J 24: 2768-2782.
44. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, et al. (2004) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36: 55-62.
45. Waldman T, Kinzler KW, Vogelstein B, (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190.
46. Stuven T, Hartmann E, Gorlich D, (2003) Exportin 6: A novel nuclear export receptor that is specific for profilin.actin complexes. EMBO J 22: 5928-5940.
47. Bugyi B, Carlier MF, (2010) Control of actin filament treadmilling in cell motility. Ann Rev Biophys 39: 449-470.
48. Metcalfe S, Weeds A, Okorokov AL, Milner J, Cockman M, et al. (1999) Wild-type p53 protein shows calcium-dependent binding to F-actin. Oncogene 18: 2351-2355.
49. Katsumoto T, Higaki K, Ohno K, Onodera K, (1995) Cell-cycle dependent biosynthesis and localization of p53 protein in untransformed human cells. Biol Cell 84: 167-173.
50. Zuchero JB, Belin B, Mullins RD, (2012) Actin binding to WH2 domains regulates nuclear import of multifunctional actin regulator JMY. Mol Boil Cell 23: 853-863.
51. Korwek Z, Sewastianik T, Bielak-Zmijewska A, Mosieniak G, Alster O, (2012) Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells. DNA Repair 11: 864-873.
52. Rastogi RP, Richa Kumar A, Tyagi MB, Sinha RP, (2010) Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010: 592980.
53. Woodring PJ, Hunter T, Wang JY, (2001) Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J Biol Chem 276: 27104-27110.
54. Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, et al. (2001) c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol Cell Boil 21: 5869-5878.
55. Jung YS, Qian Y, Chen X, (2010) Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 22: 1003-1012.